companydata.dkDATAPHARM A/S: Financial statements 2024
CVR: 72323211
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK 650,613 compared with DKK 703,717 the year before. Equity amounted to DKK 11,092,867. The solvency ratio was 77.6%.
- Profit/Loss
- 650,613 kr.
- Equity
- 11,092,867 kr.
- Total Assets
- 14,295,027 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | 651 t. | 11.1 mio. | 0 |
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
| 2020 | - | - | 305 t. | 8.3 mio. | 0 |
How creditworthy is DATAPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
DATAPHARM A/S has published its annual report for 2023. The net result was DKK 703,717.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity amounted to DKK 11,750,274.